tirzepatide and allodynia GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & ⚠️ New Sensory Side Effects
Description
Copyright 2026, Eli Lilly and Company
Slowly press the plunger until all the medication has been injected
Hypoglycemia Risk Tirzepatide, when used with insulin or sulfonylureas , can lead to low blood sugar (hypoglycemia)
In a post-hoc analysis of SURPASS-4 data, tirzepatide slowed the rate of decline in eGFR, showed clinically meaningful improvement in albuminuria and significantly lowered occurrence of the composite kidney outcomes compared to insulin glargine which may be related to SBP lowering [40]
Others barely notice the scale move until week eight, when suddenly everything shifts
MOUNJARO (tirzepatide)
